newsfilter
← Latest News
GlobeNewswire·

Turn Therapeutics Appoints Arthur Golden to Board of Directors

  • Turn Therapeutics appointed Arthur Golden to its Board of Directors as a senior corporate board advisor with expertise in M&A, shareholder relations, compliance, and governance.
  • Mr. Golden previously served as a Director at Emerson Electric for 24 years, where he chaired the Corporate Governance & Finance Committees & was a member of the Executive Committee.
  • He currently acts as Senior Counsel at Davis Polk & Wardwell LLP after spending over 40 years as a partner guiding Fortune 500 companies through transactions, governance evolution, & risk management.
  • CEO Bradley Burnam stated that Golden's experience in global corporate governance & capital market dynamics will be invaluable as Turn advances late-stage programs & expands commercial reach.
  • Mr. Golden emphasized that sound governance, capital discipline, & regulatory focus are critical for Turn's growth at this inflection point.
  • Turn Therapeutics is developing dermatology, wound care, & anti-infective therapies, holding three FDA clearances & advancing late-stage clinical programs for eczema & onychomycosis.
  • The Company also pursues global health initiatives involving thermostable vaccine delivery for underserved areas worldwide.
  • Golden holds a JD from NYU School of Law & a BS in Mathematics from Rensselaer Polytechnic Institute, where he serves as Chairman Emeritus of the Board of Trustees.